Long-term adjunctive lumateperone 42 mg treatment in major depressive disorder: Results from a 6-month open-label extension study

EUROPEAN NEUROPSYCHOPHARMACOLOGY · Published 2026-03-24 · DOI 10.1016/j.euroneuro.2026.112786

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.euroneuro.2026.112786

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles